Nyxoah SA Net Profit Margin 2021-2024 | NYXH
Nyxoah SA net profit margin from 2021 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Nyxoah SA Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-12-31 | $0.00B | $-0.06B | -1600.00% |
| 2024-09-30 | $0.01B | $-0.06B | -1160.00% |
| 2024-06-30 | $0.01B | $-0.05B | -940.00% |
| 2024-03-31 | $0.01B | $-0.05B | -940.00% |
| 2023-12-31 | $0.00B | $-0.05B | -1175.00% |
| 2023-09-30 | $0.00B | $-0.05B | -1633.33% |
| 2023-06-30 | $0.00B | $-0.05B | -2350.00% |
| 2023-03-31 | $0.00B | $-0.04B | -1900.00% |
| 2022-12-31 | $0.00B | $-0.03B | -1100.00% |
| 2022-03-31 | $0.00B | $-0.02B | -1500.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.197B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.242B | 54.20 |
| Hims & Hers Health (HIMS) | United States | $14.325B | 148.84 |
| Tempus AI (TEM) | United States | $11.867B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 73.62 |
| IRhythm Technologies (IRTC) | United States | $4.463B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.134B | 11.90 |
| Clover Health Investments (CLOV) | United States | $1.737B | 0.00 |
| Schrodinger (SDGR) | United States | $1.735B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.312B | 23.14 |
| Azenta (AZTA) | United States | $1.277B | 59.36 |
| 10x Genomics (TXG) | United States | $1.180B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.589B | 0.00 |
| Talkspace (TALK) | United States | $0.514B | 153.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Standard BioTools (LAB) | United States | $0.433B | 0.00 |
| Claritev (CTEV) | United States | $0.405B | 0.00 |
| TruBridge (TBRG) | United States | $0.375B | 831.67 |
| Health Catalyst (HCAT) | United States | $0.299B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.208B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.156B | 0.00 |
| Pulmonx (LUNG) | United States | $0.133B | 0.00 |
| American Well (AMWL) | United States | $0.119B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.19 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |